Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.4.0.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Revenue $ 383 $ 0
Revenue - from a related party 277 500
Total revenue 660 500
Operating expenses    
Research and development 7,736 1,642
Research and development - licenses acquired 83 7,439
General and administrative 7,932 3,490
Total operating expenses 15,751 12,571
Loss from operations (15,091) (12,071)
Other income (expenses)    
Interest income 75 82
Interest expense (620) (331)
Change in fair value of subsidiary's warrant liabilities (89) 0
Change in fair value of investments (918) (215)
Total other income (expenses) (1,552) (464)
Net loss (16,643) (12,535)
Less: net loss attributable to non-controlling interests 4,438 479
Net loss attributable to common stockholders $ (12,205) $ (12,056)
Basic and diluted net loss per common share $ (0.31) $ (0.31)
Weighted average common shares outstanding—basic and diluted 39,658,188 38,574,702